Spark Therapeutics

$80$125

Spark Therapeutics is a fully integrated company committed to discovering, developing, and delivering gene therapies. The Company is focusing to challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. The company engineered investigational gene therapy vectors using a cutting-edge, proprietary adeno-associated viral (AAV) vector platform, developed through vigorous preclinical and clinical testing. The company employees a diverse, experienced team in to break down barriers for people and families affected by genetic diseases

Report ID:

UMHE21216

Published:

Jan-2022

Pages:

11

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMSE21215 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company’s Scientific Platform and Programs
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Company Timeline
7.    SWOT Analysis
8. Recent Developments
8.1 Product Launches
8.2 Partnerships, Mergers and Acquisitions”

Companies Mentioned

“Roche
Novartis Pharmaceuticals”